Zobrazeno 1 - 2
of 2
pro vyhledávání: '"David M. Tierney MD, FACP"'
Autor:
Roman Melamed MD, FCCP, Catherine A. St. Hill DVM, PhD, Bjorn I. Engstrom MD, David M. Tierney MD, FACP, Claire S. Smith MS, Vincent K. Agboto PhD, MS, Brynn E. Weise MD, Peter M. Eckman MD, FACC, Nedaa Skeik MD, FACC
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Pulmonary embolism (PE) treatment depends on disease severity and risk of complications. Physician and institutional expertise may influence the use of reperfusion therapy (RT) such as systemic thrombolysis (SL) and catheter-directed interventions (C
Externí odkaz:
https://doaj.org/article/0a4d5d1c73e449fa9e5c824097e583b4
Autor:
Adam Wolfe MD, Angela Phillips MD, David M Tierney MD, FACP, Roman Melamed MD, FCCP, Ghazi Qadri MD, Matthew Lillyblad PharmD, BCCCP, BCCP, Claire Smith MS, Catherine St. Hill DVM, PhD, Ashley E Stenzel PhD, David Beddow MD, Justin Kirven MD, Rajesh Kethireddy MD, Love Patel MD, SFHM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Direct-acting oral anticoagulants (DOACs) are prescribed in the treatment of venous thromboembolism, including pulmonary embolism (PE). Evidence is limited regarding the outcomes and optimal timing of DOACs in patients with intermediate- or high-risk
Externí odkaz:
https://doaj.org/article/4d72bd952fb4476288cd1e82fe8733a3